Peritoneal gliomatosis in ovarian teratoma: a brief review of the literature and a case report

   Malignant neoplasms of the pelvic organs and abdominal cavity are often associated with peritoneal gliomatosis (PG). Detection of PG and its differentiation from carcinomatosis and other changes in the tissue using ultrasound, magnetic resonance imaging, computed tomography is extremely limited. Questions of the pathogenesis of PG, its influence on the course of the main tumor process, as well as the relationship with indicators of overall and relapse-free survival remain debatable. We believe that the description of the PG encountered in practice is extremely relevant in the aspect of considering the possibility of the presence of such a pathology in the tumor process and the inclusion of PG in the differential diagnostic series in the diagnosis of changes in the omentum and peritoneum of the small pelvis and abdominal cavity using various methods (ultrasound, magnetic resonance imaging, intraoperative urgent histological examination).

1. Coulson W. F. Peritoneal gliomatosis from a gastric teratoma. Am J Clin Pathol 1990; 94(1): 87–9. DOI: 10.1093/ajcp/94.1.87

2. Torikai M., Tahara H., Kaji T. et al. Immature teratoma of gallbladder associated with gliomatosis peritonei: a case report. J Pediatr Surg 2007; 42 (10): E25–7. DOI: 10.1016/j.jpedsurg.2007.08.001

3. Lorusso D., Malaguti P., Trivellizzi I. N. et al. Unusual liver locations of growing teratoma syndrome in ovarian malignant germ cell tumors. Gynecol Oncol Case Rep 2011; 1 (1): 24–5. DOI: 10.1016/j.gynor.2011.08.001

4. Shefren G., Collin J., Soriero O. Gliomatosis peritonei with malignant transformation: a case report and review of the literature. Am J Obstet Gynecol 1991; 164 (6Pt 1): 1617–20; discussion 1620–1. DOI: 10.1016/0002-9378(91)91445-3

5. Dadmanesh F., Miller D., Swenerton K., Clement P. Gliomatosis peritonei with malignant transformation. Mod Pathol 1997; 10 (6): 597–601.

6. Lobotesis K., U-King-Im J. M, Cross J. J. et al. Gliomatosis peritonei associated with a ventriculo-peritoneal shunt. Clin Radiol 2009; 64 (1): 95–9. DOI: 10.1016/j.crad.2008.08.015

7. Wang D., Jia C. W., Feng R. E. et al. Gliomatosis peritonei: a series of eight cases and review of the literature. J Ovarian Res 2016; 9 (1): 45. DOI: 10.1186/s13048-016-0256-5

8. Harms D., Jänig U., Göbel U. Gliomatosis peritonei in childhood and adolescence. Clinicopathological study of 13 cases including immunohistochemical findings. Pathol Res Pract 1989; 184 (4): 422–30. DOI: 10.1016/S0344-0338(89)80038-X

9. Liang L., Zhang Y., Malpica A. et al. Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases. Mod Pathol 2015; 28 (12): 1613–20. DOI: 10.1038/modpathol.2015.116

10. Yoon N. R., Lee J. W., Kim B. G. et al. Gliomatosis peritonei is associated with frequent recurrence, but does not affect overall survival in patients with ovarian immature teratoma. Virchows Arch 2012; 461 (3): 299–304. DOI: 10.1007/s00428-012-1285-0

11. Ferguson A. W., Katabuchi H., Ronnett B. M., Cho K. R. Glial implants in gliomatosis peritonei arise from normal tissue, not from the associated teratoma. Am J Pathol 2001; 159 (1): 51–5. DOI: 10.1016/S0002-9440(10)61672-0

12. Kwan M. Y., Kalle W., Lau G. T., Chan J. K. Is gliomatosis peritonei derived from the associated ovarian teratoma? Hum Pathol 2004; 35 (6): 685–8. DOI: 10.1016/j.humpath.2004.01.025

13. Li J., Li S., Xiao D. et al. Extratesticular gliomatosis peritonei after mesenteric teratoma: a case report and literature review. J Int Med Res 2021; 49 (9): 3000605211047076. DOI: 10.1177/03000605211047076

14. Nielsen S. N., Scheithauer B. W., Gaffey T. A. Gliomatosis peritonei. Cancer 1985; 56 (10): 2499–503. DOI: 10.1002/1097-0142(19851115)56:10<2499::AID-CNCR2820561029>3.0.CO;2-0

15. Robboy S. J., Scully R. E. Ovarian teratoma with glial implants on the peritoneum. An analysis of 12 cases. Hum Pathol 1970; 1 (4): 643–53. DOI: 10.1016/s0046-8177(70)80062-4

16. England R. A., de Souza N. M., Kaye S. B. Gliomatosis peritonei: MRI appearances and its potential role in follow up. Br J Radiol 2007; 80 (953): e101–4. DOI: 10.1259/bjr/16457460

17. Levy A. D., Shaw J. C., Sobin L. H. Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation. Radiographics 2009; 29 (2): 347–73. DOI: 10.1148/rg.292085189

18. Heda S. A., Patrikar A. D., Bothale K. A., Mahore S. D. A rare case of immature ovarian teratoma with gliomatosis peritonei. J Basic Clin Reprod Sci 2014; 3 (2): 126–9. DOI: 10.4103/2278-960X.140092

19. Das C. J., Sharma R., Thulkar S. et al. Mature ovarian teratoma with gliomatosis peritonei: a case report. Indian J Cancer 2005; 42 (3): 165–7. DOI: 10.4103/0019-509x.17064

20. Hill D. A., Dehner L. P., White F. V., Langer J. C. Gliomatosis peritonei as a complication of a ventriculoperitoneal shunt: case report and review of the literature. J Pediatr Surg 2000; 35 (3): 497–9. DOI: 10.1016/s0022-3468(00)90221-5

21. Gu S., Wu Y. M., Hong L. et al. Glial fibrillary acidic protein expression is an indicator of teratoma maturation in children. World J Pediatr 2011; 7 (3): 262–5. DOI: 10.1007/s12519-011-0258-8

22. Müller A. M., Söndgen D., Strunz R., Müller K. M. Gliomatosis peritonei: a report of two cases and review of the literature. Eur J Obstet Gynecol Reprod Biol 2002; 100 (2): 213–22. DOI: 10.1016/s0301-2115(01)00486-9

23. Fortt R. W., Mathie I. K. Gliomatosis peritonei caused by ovarian teratoma. J Clin Pathol 1969; 22 (3): 348–53. PMID: 5784983. DOI: 10.1136/jcp.22.3.348

24. Nogales F. F., Preda O., Dulcey I. Gliomatosis peritonei as a natural experiment in tissue differentiation. Int J Dev Biol 2012; 56 (10–12): 969–74. DOI: 10.1016/j.cell.2007.11.019

25. Takahashi K., Tanabe K., Ohnuki M. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131 (5): 8611–72.URL: https://pubmed.ncbi.nlm.nih.gov/18035408/

26. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126 (4): 663–76. DOI: 10.1016/j.cell.2006.07.024

27. Zhang S., Cui W. Sox2, a key factor in the regulation of pluripotency and neural differentiation. World J Stem Cells 2014; 6 (3): 305–11. DOI: 10.4252/wjsc.v6.i3.305

28. Maucksch C., Jones K. S., Connor B. Concise review: the involvement of SOX2 in direct reprogramming of induced neural stem/precur sor cells. Stem Cells Transl Med 201; 2 (8): 579–83. DOI: 10.5966/sctm.2012-0179

29. Kopen G. C., Prockop D. J., Phinney D. G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 1999; 96 (19): 10711–6. DOI: 10.1073/pnas.96.19.10711

30. Furukawa S., Furukawa Y., Satoyoshi E., Hayashi K. Synthesis and secretion of nerve growth factor by mouse astroglial cells in culture. Biochem Biophys Res Commun 1986; 136 (1): 57–63. DOI: 10.1016/0006-291x(86)90876-4